Nextech Invest logo

Nextech Invest

Europe, Zurich, Switzerland, Zürich

Description

Nextech Invest is a venture capital and private equity firm specializing in early, mid-stage, late-stage, and emerging growth.

Investor Profile

Nextech Invest has made 89 investments, with 8 in the past 12 months and 28% as lead.

Stage Focus

  • Series B (39%)
  • Series A (19%)
  • Series C (18%)
  • Post Ipo Equity (8%)
  • Series D (6%)
  • Private Equity (4%)
  • Series Unknown (3%)
  • Series E (2%)

Country Focus

  • United States (90%)
  • Germany (4%)
  • United Kingdom (2%)
  • Canada (2%)
  • Switzerland (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biopharma
  • Life Science
  • Oncology
  • Medical Device
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nextech Invest frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 20
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 11
Casdin Capital
North America, New York, United States, New York
Co-Investments: 23
Vida Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 13
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 13
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 22
The Column Group
North America, California, United States, San Francisco
Co-Investments: 14
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 14
Invus
North America, New York, United States, New York
Co-Investments: 11
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 23

Which angels does Nextech Invest often collaborate with?

JT
North America, California, United States, San Francisco
Shared Deals: 1
HT
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1
AG
North America, New Jersey, United States, New Brunswick
Shared Deals: 1
AB
North America, California, United States, Los Angeles
Shared Deals: 1
NB
North America, California, United States, San Mateo
Shared Deals: 1
JP
North America, Virginia, United States, Great Falls
Shared Deals: 1
NL
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Nextech Invest?

Be Biopharma

Cambridge, Massachusetts, United States

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

BiopharmaBiotechnologyPharmaceutical
Series CJan 15, 2025
Amount Raised: $92,000,000
Alpha9 Theranostics

Vancouver, British Columbia, Canada

Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

BiotechnologyMedicalProduct Research
Series COct 23, 2024
Amount Raised: $175,000,000
Circle Pharma

San Francisco, California, United States

Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.

BiotechnologyClinical TrialsHealth CareTherapeutics
Series DSep 3, 2024
Amount Raised: $90,000,000
Idrx

Plymouth, Massachusetts, United States

Idrx is a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment.

BiotechnologyLife ScienceOncologyProduct Research
Series BAug 7, 2024
Amount Raised: $120,000,000
Scorpion Therapeutics

Boston, Massachusetts, United States

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

BiotechnologyHealth CareLife ScienceOncologyPrecision Medicine
Series CJul 16, 2024
Amount Raised: $150,000,000
Circle Pharma

San Francisco, California, United States

Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides.

BiotechnologyClinical TrialsHealth CareTherapeutics
Series DJul 2, 2024
Amount Raised: $54,171,999
Context Therapeutics

Philadelphia, Pennsylvania, United States

Context Therapeutics is a clinical-stage biopharmaceutical company.

BiotechnologyHealth Care
Post Ipo EquityMay 2, 2024
Amount Raised: $100,000,000
Delphia Therapeutics

Cambridge, Massachusetts, United States

Delphia Therapeutics operates and manages a laboratory that develops treatments for cancer cells.

Health CareMedicalTherapeutics
Series AMay 2, 2024
Amount Raised: $67,000,000
Alterome Therapeutics

San Diego, California, United States

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

BiopharmaBiotechnologyPharmaceutical
Series BApr 3, 2024
Amount Raised: $132,000,000
Tubulis

Munich, Bayern, Germany

Tubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series BMar 14, 2024
Amount Raised: $139,300,472